Supernus Pharmaceuticals Inc. (SUPN) at a glance
Supernus Pharmaceuticals Inc. (SUPN) is a mid-cap Healthcare company. It trades at $43.75, with a P/E of 40.7, a -13.2% profit margin and revenue growth of 32.4%. It does not pay a dividend. Vestovix scores it 55/100 overall. Its strongest dimension is Growth (88/100) and its weakest is Momentum (18/100). It is a relatively defensive holding with below-market volatility.
- Price
- $43.75
- Market cap
- $2.54B
- P/E ratio
- 40.7
- Dividend yield
- None
- Beta
- 0.56
- 52-week range
- $42.45 to $59.68
Value
36
Growth
88
Income
40
Safety
70
Momentum
18
Other Healthcare stocks
See allDHR.PR.A50
Danaher Corp
$1,841.01+0.00%
2.58% yield
LLY68
Eli Lilly and Company
$1,170.23-0.96%
0.57% yield
JNJ61
Johnson & Johnson
$268.94+0.73%
2.18% yield
ABBV46
AbbVie Inc.
$265.10-0.86%
2.96% yield
UNH56
UnitedHealth Group Incorporated
$373.29-0.34%
2.16% yield
MRK60
Merck & Co., Inc.
$150.95-0.98%
2.79% yield
ABT54
Abbott Laboratories
$103.69+0.92%
2.16% yield
AMGN65
Amgen Inc.
$410.34-1.05%
2.76% yield